Andrew Edgecliffe-Johnson of the Financial Times writes Thursday that Bloomberg LP is joining forces with an online network for doctors to launch a service allowing investors in pharmaceutical companies to monitor and solicit physicians’ opinions on new drugs, medical devices and therapies.
“Daniel Palestrant, chief executive of Sermo, said he expected doctors to welcome the chance to share their opinions with investors. ‘The community is happiest when its voice is being heard,’ he said.
“Sachin Roopani, who developed Bloomberg’s healthcare service, said the Healthcare Exchange would provide investors with faster responses from a larger group than existing expert matching services.
“Bloomberg, which will share revenues from the service with Sermo, was looking to develop similar products for other industries, he added.”
Read more here.
Wall Street Journal reporter Hannah Miao is moving to Singapore to cover the China economy.…
Financial Times reporter Simon Foy is now covering European banks. He has been covering accounting for the…
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…
View Comments
Their terminal is phenomenal, and this new service is intriguing - as someone who tracks pharmaceutical stocks for a living, it will be interesting to see what sort of insights this might provide.